Advances on the roles of circular RNA in breast cancer

doi:10.16352/j.issn.1001-6325.2022.03.007

Abstract

Abstract: Circular RNA (circRNA) is a kind of non-coding RNA with circular structure and is found in a variety of cell types. CircRNA is characterized by diversity, specificity, conservatism and stability. As an emerging non-coding regulatory molecules, circRNA can regulate the proliferation and metastasis of breast cancer (BC) mainly through the mechanism of competitive endogenous RNA, and is involved in a variety of chemotherapy resistance and affect the efficacy. Elucidating the functions and mechanisms of circRNA in BC may provide novel and effective strategies for the diagnosis and treatment of BC.

Key words: breast cancer, circular RNA, competitive endogenous RNA, chemotherapy resistance

CLC Number:

R737.9

HE Xiao, HU Wei-jie, LYU Wen-chang, REN Yu-ping, WU Min, WU Yi-ping, ZHANG Qi. Advances on the roles of circular RNA in breast cancer[J]. Basic & Clinical Medicine, 2022, 42(3): 507-511.

References

[1]郑亚男, 李梅, 赵基源. 乳腺癌骨转移分子机制及靶向药物的研究进展[J].基础医学与临床, 2021, 41:433-437.
[2]Narrandes S, Huang SJ, Murphy L, et al. The exploration of contrasting pathways in triple negative breast cancer (TNBC)[J]. BMC Cancer, 2018, 18:22. doi: 10.1186/s12885-017-3939-4.
[3]Hu Q, Zhou T. EIciRNA-mediated gene expression: tunability and bimodality[J]. FEBS Lett, 2018, 592:3460-3471.
[4]Zhang CL, Wu H, Wang YH, et al. Expression patterns of circular RNAs from primary kinase transcripts in the mammary glands of lactating rats[J]. J Breast Cancer, 2015, 18:235-241.
[5]Pagliarini V, Jolly A, Bielli P, et al. Sam68 binds Alu-rich introns in SMN and promotes pre-mRNA circulariza-tion[J]. Nucleic Acids Res, 2020, 48:633-645.
[6]Venø MT, Hansen TB, Venø ST, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development[J]. Genome Biol, 2015, 16:245. doi: 10.1186/s13059-015-0801-3.
[7]Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus[J]. Nat Struct Mol Biol, 2015, 22:256-264.
[8]Wesselhoeft RA, Kowalski PS, Anderson GD. Engineer-ing circular RNA for potent and stable translation in eukaryotic cells[J]. Nat Commun, 2018, 9:2629. doi: 10.1038/s41467-018-05096-6.
[9]Wang Q, Li Z, Hu Y, et al. Circ-TFCP2L1 promotes the proliferation and migration of triple negative breast cancer through sponging miR-7 by inhibiting PAK1[J]. J Mammary Gland Biol Neoplasia, 2019, 24:323-331.
[10]Kong Y, Yang L, Wei W, et al. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression[J]. Epigenomics, 2019, 11:1163-1176.
[11]Yang R, Xing L, Zheng X, et al. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression[J]. Mol Cancer, 2019, 18:4. doi: 10.1186/s12943-018-0933-7.
[12]Zhang J, Xu HD, Xing XJ, et al. CircRNA-069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23:5315-5322.
[13]Wang ST, Liu LB, Li XM, et al. Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway[J]. Neoplasma, 2019, 66:232-239.
[14]Ren S, Liu J, Feng Y, et al. Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia[J]. J Exp Clin Cancer Res, 2019, 38:388. doi: 10.1186/s13046-019-1398-2.
[15]Liang G, Liu Z, Tan L, et al. HIF1α-associated circdennd4c promotes proliferation of breast cancer cells in hypoxic environment[J]. Anticancer Res, 2017, 37:4337-4343.
[16]Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer[J]. Mol Cancer, 2018, 17:160. doi: 10.1186/s12943-018-0914-x.
[17]Xu JH, Wang Y, Xu D. Hsa-circ-001569 is an unfavo-rable prognostic factor and promotes cell prolifera-tion and metastasis by modulating PI3K-AKT pathway in breast cancer[J]. Cancer Biomark, 2019, 25:193-201.
[18]Pan G, Mao A, Liu J, et al. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling[J]. Cell Prolif, 2020, 53:1-14.
[19]Lin X, Hong S, Chen J, et al. The potential targets for metastases: a study on altered circular RNA profile in breast cancer liver metastases[J]. Epigenomics, 2019, 11:1237-1250.
[20]Liang Y, Song X, Li Y, et al. CircKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer[J]. Oncogene, 2019, 38:6850-6866.
[21]Gao D, Zhang X, Liu B, et al. Screening circular RNA related to chemotherapeutic resistance in breast cancer[J]. Epigenomics, 2017, 9:1175-1188.
[22]Liang Y, Song X, Li Y, et al. Targeting the circBMPR2/miR-553/USP4 axis as a potent therapeutic approach for breast cancer[J]. Mol Ther Nucleic Acids, 2019, 17:347-361.
[23]Sang Y, Chen B, Song X, et al. CircRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer[J]. Mol Ther, 2019, 27:1638-1652.
[24]Uhr K, Sieuwerts AM, de Weerd V, et al. Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer[J]. Sci Rep, 2018, 8:9657. doi: 10.1038/s41598-018-27987-w.
[25]Liu Y, Dong Y, Zhao L, et al. Circular RNA-MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis[J]. Int J Oncol, 2018, 53:1752-1762.